-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On December 16, Tiansli announced that it had signed a Framework Agreement with Chongqing Pharmaceuticals (Group) Co., Ltd. ("Chongqing Pharmaceuticals") to sell its controlling subsidiary, Tianjin Tiansli Pharmaceutical Marketing Group Co., Ltd. ("Tiansli Marketing").According to the Agreed Framework, Chongqing Pharma intends to acquire 87.47 percent of Tiansli's direct and indirect stake in Tiansli Marketing and the shares held by Tiansli Marketing's other shareholders by way of cash-for-price.The parties to the transaction intend to determine the final transaction price in consultation with the Asset Assessment Report of the underlying assets as the base date for the assessment of 31 December 2019 (the Underlying Asset Assessment Report will be issued by an asset appraisal institution qualified for securities business).
(Sina Pharmaceutical News)